Jobs für corruption bei Basel
8 corruption Stellenangebote in Schweiz. Täglich aktualisierte Angebote.
-
Basel, Basel-Stadt, Schweiz Revolution Medicines VollzeitppRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...
-
Senior Specialist, IT
Vor 4 Tagen
Basel, Kanton Basel-Stadt, Schweiz Basel Institute on Governance VollzeitSenior Specialist, ITSenior Specialist, ITPlace of work: Basel, SwitzerlandEmployment rate: 50–100%Start date: 1 January 2027 or soonerContract type: PermanentOther: Must be eligible to work in SwitzerlandBasel Institute on GovernanceThe Basel Institute on Governance is a hands-on centre of competence dedicated to promoting good governance and countering...
-
Senior Specialist, IT
Vor 2 Wochen
Basel, Basel, BS, Schweiz ETH get hired VollzeitBeschreibung Facebook Twitter LinkedIn of 3 100% Basel Institute on Governance Steinenring 60 | 4051 Basel, Switzerland | +41 61 205 55 11 info@baselgovernance.org | www.baselgovernance.org Senior Specialist, IT Place of work: Basel, Switzerland Employment rate: 50–100% Start date: 1 January...
-
Senior Specialist, IT
Vor 2 Wochen
Basel, BS, BS, Schweiz Universität Basel Remote VollzeitPlace of work: Basel, Switzerland Employment rate: 50–100% Start date: 1 January 2027 or sooner Contract type: Permanent Other: Must be eligible to work in Switzerland **Basel Institute on Governance** The Basel Institute on Governance is a hands-on centre of competence dedicated to promoting good governance and countering corruption for...
-
Basel, Basel, BS, Schweiz Revolution Medicines VollzeitRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...